The global bronchoscopy market size is expected to reach USD 3,174.0 Million in 2030 and register a revenue CAGR of 5.5% during the forecast period. Market revenue growth can be attributed to rising prevalence of respiratory diseases, including infections, inhalation of passive tobacco smoke, and air pollution caused by automotive exhaust emissions. Asthma and COPD (chronic obstructive pulmonary disease) are leading respiratory diseases caused by air pollution. Other respiratory diseases include pulmonary fibrosis, pneumonia, and lung cancer.
Increasing tobacco smoking, especially a rising tendency of smoking in youth is increasing the prevalence of respiratory disorders. Additionally, rapid industrialization has resulted in increasing air pollution levels, which has increased the incidence of respiratory disorders, and in turn, demand for bronchoscopy.
Lung cancer, including small cell & non-small cell lung cancer, is the second most leading cause of cancer in both males and females. Lung cancer primarily occurs in geriatric people, with a majority of lung cancer patients lying in the age group of 65 years or above. Only a small percentage of the population is diagnosed with this cancer at age younger than 45.
Lung cancer accounts for about 25% of all cancer deaths. Every year, numerous people die due to lung cancer as compared to breast, colon, and prostate cancers combined. Thus, a rise in lung cancer cases will fuel demand for bronchoscopy for diagnosis and treatment application.
The market is expected to grow continuously over the forecast period due to technological advancements in bronchoscopy, as well as improvements in medical and healthcare infrastructure. Also, bronchoscopy remains an essential and useful tool for diagnosing and treating lung disorders, which in certain cases, cannot be postponed due to disease progression or clinical worsening. As a result, it is vital to distinguish between individuals who require immediate bronchoscopy intervention, and those who could benefit from delayed treatment.
Driver: Rise in air pollution
Air pollution is responsible for 9% of worldwide deaths, and this figure varies from 2% to 15% on a country basis. Breathing in pollutants in air can irritate your airways, leading to shortness of breath, wheezing, coughing, asthma episodes, and chest pain. Further, exposure to air pollution can also result in lung cancer and in extreme cases, premature death. Hence, due to a rise in air pollution levels across the globe, demand for bronchoscopy will increase for the treatment of lung disorders.
Restraint: Lack of expertise and specialized pulmonologist
The market is likely to be limited over the forecast period due to lack of skilled and capable specialists, higher device costs, and risk of device infection associated with the handling of reusable bronchoscopes.
The COVID-19 pandemic has caused disruption in healthcare workflows around the world. Various industries, including several sub-domains of healthcare, have been forced to temporarily shift focus from other types on non-severe illnesses. However, there has been an increase in demand for a variety of medical services and products, including bronchoscopy devices, such as visualization systems and endoscopes.
Bronchoscopy is an aerosol-producing method with a variety of diagnostic and therapeutic applications. However, even after coronavirus (COVID-19) pandemic, airway operations can raise a risk of COVID-19 exposure and transmission among healthcare personnel, which may hamper market revenue share.
Component Type Insights:
Based on component type, the global bronchoscopy market is segmented into endoscope, visualization system, accessories, and other products. The endoscope segment revenue is expected to grow at a faster rate over the forecast period. Endoscopes allow doctors to examine lungs or air pathways with a non-surgical procedure where the patient doesn’t need to go through any anesthesia. This is why demand for endoscopes is rising for examining disorder of the respiratory tract.
Based on usability, the global bronchoscopy market is segmented into disposable equipment and reusable equipment. The disposable equipment segment revenue is expected to grow at the fastest rate over the forecast period. Absence of cross-contamination, fast availability, and lack of reprocessing expenses are contributing to segment’s revenue growth.
Patient type Insights:
Based on patient type, the global bronchoscopy market is segmented into adult patients and pediatric patients/neonates. The adult patient segment accounted for largest revenue share in 2020. Rising population, increase in pollution or use of harmful gases, and chronic illnesses, such as respiratory diseases, lung cancer, and air pathway blockages are contributing to revenue growth of this segment.
Based on end-use type, the global bronchoscopy market is segmented into hospitals, ambulatory surgical centers & clinics, and diagnostic centers. The hospitals segment accounted for largest revenue share of the bronchoscopy market in 2020. High revenue share of this segment can be attributed to increased patient preference for hospital-based treatments due to the availability of technologically advanced equipment, presence of skilled doctors, better healthcare infrastructure, and reimbursement policies.
The bronchoscopy market in North America accounted for largest revenue share in 2020. Growth in chronic respiratory illnesses, favorable reimbursement policies, and rising incidence of lung cancer in the US are contributing to North America's significant revenue share in the global bronchoscopy market. Also, the Asia-Pacific market revenue share is expected to rise significantly throughout the forecast period due to rising healthcare infrastructure, technological improvements, and presence of a large patient population in the region.
Companies profiled in the global market report include Olympus Corporation (Japan), KARL STORZ (Germany), Fujifilm Holdings Corporation (Japan), Ambu A/S (Denmark), Boston Scientific (US), Medtronic (Ireland), COOK Group Corporation (US), Johnson & Johnson Pvt. Ltd. (US), Hoya Corporation (Japan), Richard & Wolf GmbH (Germany).
Some recent developments are as follows:
In September 2020, Olympus Europa announced the introduction of EVIS X1 bronchoscopy system in Europe and MEA. The EVIS X1 offers bronchoscopy solutions to support a more precise diagnosis by merging highly intricate yet easy-to-use imaging advances with improved tracheobronchial access.
In December 2020, Ambu Inc., a leading provider of single-use endoscopes, made an announcement about receiving a national single-use endoscopy contract from a leading U.S. Group Purchasing Organization in Single-Use Endoscopes (GPO) field. The deal encompasses the single-use endoscopy category, enabling Ambu to service about 20% of all acute care hospitals in the US.
Segments Covered in the Report
This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides an analysis of the market trends in each of the sub-segments from 2019 to 2030. For this study, Reports and Data has segmented the bronchoscopy market based on component type, usability, patient type, end-use, application, and region:
Bronchoscopy Market Report Scope
Segments covered By Component Type Outlook, Usability Outlook, Patient Type Outlook , End-Use Outlook ,Application Outlook ,Regional Outlook
By Component Type Outlook
By Usability Outlook
By Patient Type Outlook
By End-Use Outlook
Ambulatory surgical centers and clinics
By Application Outlook
Middle East & Africa